Logo IZB Innovations- und Gründerzentrum Biotechnologie
IZB Signet

How can academic biotech teams fund their preclinical phase without giving away too much equity? Nucleate Germany presents two Bavarian funding routes that come without dilution: the m4 Award (up to €500,000 over two years, no company formation required) and EXIST-Forschungstransfer.

With Dr. Petra Burgstaller (BioM) and Dr. Philipp Ewald Baaske (LMU Munich), more speakers to be announced.

18:30 Doors · 19:00 Intro · 19:15 Panel & open Q&A

Participation is free of charge, seats are limited (40). Registration via Luma required.

Register

menuchevron-down